Eli Lilly and Company (LLY) to Issue Quarterly Dividend of $1.73 on September 10th

Eli Lilly and Company (NYSE:LLY) declared a quarterly dividend on Monday, June 22nd. Investors of record on Friday, August 14th will be paid a dividend of 1.73 per share on Thursday, September 10th. This represents a c) dividend on an annualized basis and a dividend yield of 0.6%. The ex-dividend date of this dividend is Friday, August 14th.

Eli Lilly and Company has increased its dividend by an average of 0.2%annually over the last three years and has raised its dividend every year for the last 11 years. Eli Lilly and Company has a payout ratio of 23.3% meaning its dividend is sufficiently covered by earnings. Equities analysts expect Eli Lilly and Company to earn $45.49 per share next year, which means the company should continue to be able to cover its $6.92 annual dividend with an expected future payout ratio of 15.2%.

Eli Lilly and Company Stock Down 1.5%

LLY opened at $1,212.96 on Wednesday. The firm has a market cap of $1.14 trillion, a P/E ratio of 40.70, a price-to-earnings-growth ratio of 1.45 and a beta of 0.51. The company has a debt-to-equity ratio of 1.41, a quick ratio of 1.00 and a current ratio of 1.35. The business has a 50 day moving average price of $1,165.35 and a 200 day moving average price of $1,049.90. Eli Lilly and Company has a twelve month low of $629.40 and a twelve month high of $1,249.45.

Eli Lilly and Company (NYSE:LLY) last announced its quarterly earnings results on Wednesday, August 5th. The company reported $8.38 EPS for the quarter, beating the consensus estimate of $6.40 by $1.98. Eli Lilly and Company had a return on equity of 97.83% and a net margin of 33.53%.The company had revenue of $22.97 billion for the quarter, compared to the consensus estimate of $20.82 billion. During the same quarter last year, the company posted $6.31 earnings per share. The company’s revenue for the quarter was up 47.7% compared to the same quarter last year. Eli Lilly and Company has set its FY 2026 guidance at 35.500-36.500 EPS. Research analysts forecast that Eli Lilly and Company will post 36.33 EPS for the current year.

About Eli Lilly and Company

Eli Lilly and Company (NYSE: LLY) is a global pharmaceutical company founded in 1876 and headquartered in Indianapolis, Indiana. The company researches, develops, manufactures and commercializes a broad range of medicines and therapies for patients worldwide. Eli Lilly maintains operations and commercial presence across North America, Europe, Asia and other regions, serving both developed and emerging markets. The company has been led in recent years by President and Chief Executive Officer David A.